Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02607813 |
Title | Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | NLD | ITA | FRA | ESP | DEU | CHE | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Massachusetts General Hospital MGH Cancer Center | Boston | Massachusetts | 02114 | United States | Details | |
Memorial Sloan Kettering Cancer Center SC - LXH254X2101 | New York | New York | 10065 | United States | Details | |
UT M.D Anderson Cancer Center SC - LXH254X2101 | Houston | Texas | 77030 | United States | Details | |
Novartis Investigative Site | Toronto | Ontario | M5G 2C1 | Canada | Details | |
Novartis Investigative Site | Paris Cedex 10 | 75475 | France | Details | ||
Novartis Investigative Site | Toulouse | 31059 | France | Details | ||
Novartis Investigative Site | Heidelberg | 69120 | Germany | Details | ||
Novartis Investigative Site | Milano | MI | 20133 | Italy | Details | |
Novartis Investigative Site | Modena | MO | 41124 | Italy | Details | |
Novartis Investigative Site | Napoli | 80131 | Italy | Details | ||
Novartis Investigative Site | Chuo ku | Tokyo | 104 0045 | Japan | Details | |
Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details | ||
Novartis Investigative Site | Groningen | 9713 GZ | Netherlands | Details | ||
Medical Oncology, Erasmus MC | Rotterdam | 3075 CE | Netherlands | Details | ||
Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
Novartis Investigative Site | Madrid | 28009 | Spain | Details | ||
Novartis Investigative Site | Madrid | 28046 | Spain | Details | ||
Novartis Investigative Site | Zuerich | 8091 | Switzerland | Details |